These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22008761)

  • 1. Experience with rifabutin replacing rifampin in the treatment of tuberculosis.
    Horne DJ; Spitters C; Narita M
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1485-9, i. PubMed ID: 22008761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
    Loeliger A; Suthar AB; Ripin D; Glaziou P; O'Brien M; Renaud-Thery F; Crowley S; Williams B; Ridzon R; Granich R; Gilks C
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):6-15. PubMed ID: 21819645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD; Quan DJ; Chin-Hong PV; Roberts JP
    Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis.
    Jo KW; Ji W; Hong Y; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Feb; 107(2):292-7. PubMed ID: 23199704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis.
    Wang YC; Salvador NG; Lin CC; Wu CC; Lin TL; Lee WF; Chan YC; Chen CL; Co JS; Encarnacion DD
    Biomed J; 2021 Dec; 44(6 Suppl 2):S162-S170. PubMed ID: 35300949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X
    J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of rifabutin in cases of toxicity to rifampicin].
    Moreno González B; Rodríguez Blanco A; Rodríguez Barrientos R; Vidal Pérez JL; Noguerado Asensio A
    Rev Clin Esp; 2005 Sep; 205(9):430-2. PubMed ID: 16194477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis.
    McGregor MM; Olliaro P; Wolmarans L; Mabuza B; Bredell M; Felten MK; Fourie PB
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1462-7. PubMed ID: 8912765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice.
    Reddy MV; Luna-Herrera J; Daneluzzi D; Gangadharam PR
    Tuber Lung Dis; 1996 Apr; 77(2):154-9. PubMed ID: 8762850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients].
    Morimoto K; Yoshiyama T; Kuse M; Okumura M; Sasaki Y; Yoshimori K; Ogata H; Kurashima A; Kudoh S
    Kekkaku; 2013 Aug; 88(8):625-8. PubMed ID: 24044166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
    Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    Akkerman OW; Alffenaar JWC
    J Antimicrob Chemother; 2019 Mar; 74(3):834. PubMed ID: 30508093
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifabutin: where do we stand in 2016?
    Crabol Y; Catherinot E; Veziris N; Jullien V; Lortholary O
    J Antimicrob Chemother; 2016 Jul; 71(7):1759-71. PubMed ID: 27009031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic dilemma: treatment outcomes of tuberculosis patients with inconsistent rifampicin susceptibility.
    Pang Y; Ruan YZ; Zhao J; Chen C; Xu CH; Su W; Huan ST; Li RZ; Zhao YL; Chin DP; Wang LX
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):357-62. PubMed ID: 24670576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the Critical Concentration of Rifabutin for Susceptibility Testing Using the Proportion Method with Löwenstein-Jensen Medium against Mycobacterium Tuberculosis Isolates.
    Dai G; Chen S; Dong L; Li YX; Huo F; Shang Y; Huang H
    Lab Med; 2019 Jul; 50(3):292-297. PubMed ID: 30806669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.